Found: 13
Select item for more details and to access through your institution.
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 15, p. 1, doi. 10.2807/1560-7917.ES.2024.29.15.2300352
- By:
- Publication type:
- Article
Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 6, p. 999, doi. 10.3390/antibiotics12060999
- By:
- Publication type:
- Article
Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 2, p. 210, doi. 10.3390/antibiotics10020210
- By:
- Publication type:
- Article
Antimicrobial Diterpene Alkaloids from an Agelas citrina Sponge Collected in the Yucatán Peninsula.
- Published in:
- Marine Drugs, 2022, v. 20, n. 5, p. 298, doi. 10.3390/md20050298
- By:
- Publication type:
- Article
Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds.
- Published in:
- Marine Drugs, 2020, v. 18, n. 7, p. 369, doi. 10.3390/md18070369
- By:
- Publication type:
- Article
In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa.
- Published in:
- Marine Drugs, 2020, v. 18, p. 326, doi. 10.3390/md18060326
- By:
- Publication type:
- Article
Involvement of HisF in the Persistence of Acinetobacter baumannii During a Pneumonia Infection.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2019, v. 9, p. 1, doi. 10.3389/fcimb.2019.00310
- By:
- Publication type:
- Article
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2591, doi. 10.1093/jac/dkae263
- By:
- Publication type:
- Article
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 5, p. 1195, doi. 10.1093/jac/dkad062
- By:
- Publication type:
- Article
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.
- Published in:
- 2020
- By:
- Publication type:
- journal article